Search results for "Marker"

showing 10 items of 3799 documents

Prognostic Value of New-Generation Troponins in ST-Segment-Elevation Myocardial Infarction in the Modern Era: The RUTI-STEMI Study.

2017

Background In ST ‐segment–elevation myocardial infarction ( STEMI ), troponins are not needed for diagnosis: symptoms and ECG data are sufficient to activate percutaneous coronary intervention. This study explored the prognostic value of new‐generation troponins in a real‐life cohort contemporarily treated for STEMI . Methods and Results We studied 1260 consecutive patients with primary STEMI treated with percutaneous coronary intervention between February 22, 2011, and August 31, 2015. We collected data on clinical characteristics and major adverse cardiovascular and cerebrovascular events ( MACCEs ) at 30 days and 1 year. Peak high‐sensitivity troponin T and sensitive‐contemporary tropon…

Malemedicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematologyCoronary AngiographyVentricular Function Left03 medical and health sciencesElectrocardiography0302 clinical medicinePercutaneous Coronary InterventionPredictive Value of TestsIschemiaInternal medicineCardiovascular DiseaseST segmentMedicineHumansCoronary Heart Disease030212 general & internal medicineMyocardial infarctionST‐segment–elevation myocardial infarctionAgedRetrospective StudiesOriginal ResearchAged 80 and overbiologybusiness.industrytroponinPercutaneous coronary interventionMiddle Agedmedicine.diseasePrognosisTroponinmyocardial infarctionbiology.proteinCardiologyST Elevation Myocardial InfarctionFemaleMortality/SurvivalCardiology and Cardiovascular MedicinebusinessValue (mathematics)BiomarkersJournal of the American Heart Association
researchProduct

Lipoprotein(a) and long-term recurrent infarction after an episode of ST-segment elevation acute myocardial infarction

2020

Background In established ischemic heart disease, the relationship between lipoprotein(a) and new cardiovascular events showed contradictory results. Our aim was to assess the relationship between lipoprotein(a) and very long-term recurrent myocardial infarction (MI) after an index episode of ST-segment elevation acute myocardial infarction (STEMI). Methods We included 435 consecutive STEMI patients discharged from October 2000 to June 2003 in a single teaching center. The relationship between lipoprotein(a) at discharge and recurrent MI was evaluated through negative binomial regression and Cox regression analysis. Results The mean age was 65 years (55-74 years), 25.5% were women, 34.7% we…

Malemedicine.medical_specialtymedicine.medical_treatmentInfarction030204 cardiovascular system & hematologyRate ratio03 medical and health sciences0302 clinical medicineRecurrenceInternal medicineFibrinolysismedicineRisk of mortalityHumansST segment030212 general & internal medicineMyocardial infarctionAgedRetrospective Studiesbiologybusiness.industryIncidenceGeneral MedicineLipoprotein(a)Middle Agedmedicine.diseaseConfidence intervalSpainbiology.proteinCardiologyST Elevation Myocardial InfarctionFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesForecastingLipoprotein(a)Coronary Artery Disease
researchProduct

Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation.

2013

Non-valvular atrial fibrillation is associated with an increase in thromboembolism, i.e. stroke, and atherosclerotic events, i.e. myocardial infarction. Vitamin E possesses anti-coagulant as well as anti-atherosclerotic properties. Our aim was to assess whether vitamin E is associated with cardiovascular events in patients with non-valvular atrial fibrillation.Serum levels of cholesterol-adjusted vitamin E were measured in 1012 patients with non-valvular atrial fibrillation. Patients were followed for a mean time of 27.0 months, and cardiovascular events, such as cardiovascular death and fatal and nonfatal stroke or myocardial infarction, were recorded.During the follow-up period, cardiovas…

Malemedicine.medical_specialtymedicine.medical_treatmentNon valvular atrial fibrillationVitamin e serumchemistry.chemical_compoundInternal medicineAtrial FibrillationmedicineHumansVitamin EIn patientcardiovascular diseasesMyocardial infarctionProspective StudiesStrokeAgedAged 80 and overAtrial fibrillation Cardiovascular events Vitamin Ebusiness.industryCholesterolVitamin EAtrial fibrillationMiddle Agedmedicine.diseaseCholesterolchemistrycardiovascular systemCardiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesInternational journal of cardiology
researchProduct

Presepsin and Midregional Proadrenomedullin in Pediatric Oncologic Patients with Febrile Neutropenia

2020

Abstract Objective In this study, we investigated the roles of presepsin (PSP) and midregional proadrenomedullin (mr-proADM) in children with febrile neutropenia (FN) due to chemotherapy. Methods We assessed 36 FN episodes in 26 children. Patients were classified into bacteremia (B) and fever of unknown origin (FUO) groups. We evaluated PSP and mr-proADM at admission (T0), after 24/48 h (T1), and after 5 days (T2). Results PSP and mr-proADM levels were elevated at T0 and significantly decreased at T2. mr-proADM levels did not significantly differ between the B and FUO groups. PSP levels significantly differed between the B and FUO groups only at T1. Both PSP and mr-proADM levels at T0 were …

Malemedicine.medical_specialtymedicine.medical_treatmentpediatric.Clinical BiochemistryLipopolysaccharide ReceptorsNeutropeniaAdrenomedullinmr-proADMmalignancieNeoplasmsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsHumansneutropeniaMedicineBlood cultureProtein PrecursorsFever of unknown originChildFebrile NeutropeniafeverChemotherapymedicine.diagnostic_testReceiver operating characteristicbusiness.industryPresepsinBiochemistry (medical)Age FactorsPrognosismedicine.diseasePeptide FragmentsAdrenomedullinROC CurveoncologicBacteremiaFemalebusinessBiomarkersFebrile neutropeniaLaboratory Medicine
researchProduct

Musculoskeletal Responses to Exercise Plus Nutrition in Men with Prostate Cancer on Androgen Deprivation: A 12-Month RCT

2021

PURPOSE Androgen deprivation therapy (ADT) for prostate cancer has multiple adverse effects on musculoskeletal health. This 12-month randomized controlled trial aimed to assess the effects of multicomponent exercise training combined with whey protein, calcium and vitamin D supplementation on bone mineral density (BMD), structure and strength, body composition, muscle strength, and physical function in ADT-treated men. METHODS Seventy ADT-treated men were randomized to exercise plus supplementation (Ex + Suppl; n = 34) or usual care (control; n = 36). Ex + Suppl involved thrice weekly progressive resistance training plus weight-bearing impact exercise with daily multinutrient supplementatio…

Malemedicine.medical_specialtymusclelihaksetPhysical Therapy Sports Therapy and Rehabilitationandrogen deprivation therapybonelaw.inventionravintoAndrogen deprivation therapyProstate cancerRandomized controlled trialBone DensitylawInternal medicinemedicinecancerHumansOrthopedics and Sports MedicineMuscle StrengthVitamin DAdverse effectAgedFemoral neckBone mineralluustoexercisesyöpähoidoteturauhassyöpäkuntoliikuntabusiness.industryProstatic NeoplasmsAndrogen Antagonistsmedicine.diseaseConfidence intervalExercise TherapyCalcium DietarynutritionWhey Proteinsmedicine.anatomical_structureDietary SupplementsBody CompositionLean body massPatient CompliancesyöpätauditbusinessBiomarkersMedicine & Science in Sports & Exercise
researchProduct

Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: Relationship with TOAST subtype, outcome and infarct site

2009

BACKGROUND: The aim of our study was to evaluate in patients with acute ischemic stroke the relationship between immuno-inflammatory variables, clinical outcome and infarct site. MATERIALS AND METHODS: We evaluated plasma levels of IL-1beta, TNF-alpha, IL-6 and IL-10, E-selectin, P-selectin, sICAM-1 ,sVCAM-1 vWF, TPA and PAI-1. RESULTS: Patients with cardioembolic subtype showed significantly higher median plasma levels of TNF-alpha, IL-6, IL-1beta whereas the lacunar subtype showed significantly lower median plasma levels of TNF-alpha, IL-6 and IL-1beta. CONCLUSIONS: A significant association was noted between the severity of neurological deficit at admission, the diagnostic subtype and so…

Malemedicine.medical_specialtystroke TOAST subtypeImmunologyInflammationGastroenterologyBrain IschemiaInternal medicinemedicineHumansImmunology and AllergyIn patientAcute ischemic strokeStrokeAgedNeurological deficitAged 80 and overbusiness.industryFibrinolysisIschemic strokesCerebral InfarctionPlasma levelsMiddle Agedmedicine.diseaseStrokeNeurologyPhysical therapyFemaleNeurology (clinical)Inflammation MediatorsIntracranial Thrombosismedicine.symptombusinessBiomarkersJournal of Neuroimmunology
researchProduct

Nitric oxide metabolites, leukocyte activation markers and oxidative status in dialyzed subjects.

2008

<i>Aims:</i> Our purpose was to evaluate, in a group of 42 end-stage renal disease patients who regularly undergo hemodialysis, some indexes of leukocyte activation, nitric oxide metabolites (NOx) and other parameters that reflect the oxidative stress before and after a standard hemodialysis session. <i>Methods:</i> Elastase and myeloperoxidase (MPO) were determined by means of ELISA. The NO production was evaluated by a micromethod which measures the concentration of NOx. The oxidation of polyunsaturated fatty acids was evaluated in plasma by detection of thiobarbituric acid-reactive substances (TBARS). Total antioxidant status (TAS) was obtained using spectrophotom…

Malemedicine.medical_treatmentActivation markersOxidative phosphorylationHemodialysis Oxidative status Nitric oxide Elastase MyeloperoxidasePharmacologyNitric OxideThiobarbituric Acid Reactive SubstancesAntioxidantsNitric oxidechemistry.chemical_compoundRenal DialysisLeukocytesmedicineHumansAgedPeroxidasechemistry.chemical_classificationbiologyElastaseHematologyGeneral MedicineMiddle AgedOxidative StressEnzymechemistryNephrologyMyeloperoxidaseImmunologybiology.proteinKidney Failure ChronicFemaleHemodialysisLeukocyte Elastase
researchProduct

Use of acetazolamide in the treatment of patients with refractory congestive heart failure

2018

Aims Optimal diuretic treatment of patients with refractory congestive heart failure (CHF) remains to be elucidated. In this work, we aimed to evaluate the serial changes of functional class and surrogates of fluid overload (weight and antigen carbohydrate 125) after addition of oral acetazolamide in patients with refractory CHF. Likewise, serial changes in renal function, serum electrolytes and pH were evaluated. Method This is an observational retrospective study in which 25 ambulatory patients with refractory CHF that received acetazolamide in addition to standard intensive diuretic strategy were evaluated. Longitudinal assessment of New York Heart Association (NYHA) functional class and…

Malemedicine.medical_treatmentAdministration Oral030204 cardiovascular system & hematology0302 clinical medicineNatriuretic peptidePharmacology (medical)030212 general & internal medicineDiureticsfluid overloadAged 80 and overcongestionGeneral MedicineWater-Electrolyte BalanceTreatment OutcomeCardiologyFemaleCardiology and Cardiovascular MedicineAcetazolamideGlomerular Filtration Ratemedicine.drugmedicine.medical_specialtymedicine.drug_classRenal function03 medical and health sciencesRefractoryInternal medicineWeight LossmedicineHumansAgedRetrospective StudiesHeart FailurePharmacologybusiness.industryRetrospective cohort studyRecovery of Functionmedicine.diseasediureticsAcetazolamideacetazolamideBlood pressureCA-125 AntigenHeart failureFeasibility Studiesrefractory congestive heart failureDiureticbusinessBiomarkersfeasibilityCardiovascular Therapeutics
researchProduct

A Multiplex Panel of Plasma Markers of Immunity and Inflammation in Classical Kaposi Sarcoma

2014

Kaposi sarcoma (KS) risk is affected by perturbed immunity. Herein, we compared plasma from 15 human immunodeficiency virus (HIV)–negative classic KS cases to plasma from 29 matched controls, using a multiplex panel of immunity markers. Of 70 markers, CXCL10 (IP-10), sIL-1RII, sIL-2RA, and CCL3 (MIP-1A) were strongly and significantly associated with KS, after adjustment for age and smoking status. These and previous observations are consistent with a tumor-promoting role for these cytokines, particularly CXCL10, but the small sample size and case-control design preclude firm conclusions on KS risk or pathogenesis. Larger, well-designed prospective studies are needed to better assess the as…

Malemedicine.medical_treatmentInflammationBiologySettore MED/42 - Igiene Generale E ApplicataPathogenesisKaposi SarcomaPlasma Markers of InflammationMajor Articles and Brief ReportsImmunitymedicineHumansImmunology and AllergyProspective cohort studySarcoma KaposiInflammationCase-control studyvirus diseasesPlasma Markers of Immunitymedicine.diseaseSquamous intraepithelial lesionInfectious DiseasesCytokineItalyCase-Control StudiesImmunologySarcomamedicine.symptomBiomarkers
researchProduct

Ex vivo T-cell depletion vs post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft-vs-host disease prophylaxis for allogenei…

2021

Objective To compare the efficacy and safety of CD34+ selected ex vivo T-cell depletion (TCD) vs post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil (PTCy-Sir-MMF) as graft-vs-host disease (GVHD) prophylaxis. Methods We retrospectively included patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) with either TCD (n = 38) or PTCy-Sir-MMF (n = 91). Results Cumulative incidence of neutrophil and platelet recovery was 92% vs 99% (P = .06) and 89% vs 97% (P = .3) in TCD and PTCy-Sir-MMF, respectively. Cumulative incidences of aGHVD grade II-IV, III-IV, and moderate to severe cGVHD were 11% vs 19% (P = .2), 3% vs 2% (P = .9), and 3% vs 36% (P < …

Malemedicine.medical_treatmentT-LymphocytesCD34Graft vs Host DiseaseHematopoietic stem cell transplantationMycophenolateGastroenterologySeverity of Illness IndexLeukocyte Count0302 clinical medicineImmune ReconstitutionPostoperative ComplicationsRecurrenceGVHD prophylaxisAntineoplastic Combined Chemotherapy ProtocolsCumulative incidenceHematopoietic Stem Cell TransplantationT-cell depletionHematologyGeneral MedicineMiddle AgedPrognosisLeukemia Myeloid Acutesurgical procedures operativeTreatment OutcomeT-cell depletion030220 oncology & carcinogenesishematopoietic stem cell transplantationcardiovascular systemFemalemedicine.drugAdultmedicine.medical_specialtyCyclophosphamideAdolescentLymphocyte Depletion03 medical and health sciencesYoung AdultInternal medicinemedicineHumansTransplantation HomologousGVHD prophylaxis T-cell depletion hematopoietic stem cell transplantation post-transplantation cyclophosphamideCyclophosphamideAgedPostoperative CareSirolimuspost-transplantation cyclophosphamidebusiness.industryMycophenolic AcidSirolimusbusinessEx vivoBiomarkers030215 immunologyEuropean journal of haematologyREFERENCES
researchProduct